Author

J. Angulo-Lozano

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Horowitz· 1 shared A. Tan· 1 shared B. Bochner· 1 shared C. M. Rice· 1 shared D. Hirschhorn· 1 shared D. Knorr· 1 shared D. Ranti· 1 shared G. Mazo· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Horowitz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer

J. L. Wong, P. Smith, J. Angulo-Lozano, D. Ranti, B. Bochner, J. P. Sfakianos, A. Horowitz, J. V. Ravetch, D. Knorr

This study shows that combining IL-15 with CD40 agonist antibodies improves anti-tumor immunity in bladder cancer by enhancing T cell responses and memory.

bioRxiv · Jan 30, 2023Immunology

Innate-adaptive IFN cross-talk reprograms myeloid and T cells for antitumor immunity with a second-generation recombinant MVA

S. Liu, Y. Wang, G. Mazo, S. Baseer Tariq, J. Angulo-Lozano, N. Yang, T. Zhang, Y. Wang, D. Hirschhorn, L. Ji, A. Tan, J. Wang, W. Yan, J. Choi, J. Z. Xiang, , L. Deng

This paper describes a second-generation recombinant MVA vaccine that enhances antitumor immunity by reprogramming myeloid and T cells through innate-adaptive IFN cross-talk.

bioRxiv · Sep 25, 2022 · PreprintImmunology